150 related articles for article (PubMed ID: 14764657)
1. Anthraquinone polyamines: novel channel blockers to study N-methyl-D-aspartate receptors.
Kashiwagi K; Tanaka I; Tamura M; Sugiyama H; Okawara T; Otsuka M; Sabado TN; Williams K; Igarashi K
J Pharmacol Exp Ther; 2004 Jun; 309(3):884-93. PubMed ID: 14764657
[TBL] [Abstract][Full Text] [Related]
2. Anthraquinone polyamines: novel channel blockers of N-methyl-D-aspartate receptors.
Kashiwagi K; Williams K; Igarashi K
Amino Acids; 2007 Aug; 33(2):299-304. PubMed ID: 17404801
[TBL] [Abstract][Full Text] [Related]
3. Benzyl-polyamines: novel, potent N-methyl-D-aspartate receptor antagonists.
Igarashi K; Shirahata A; Pahk AJ; Kashiwagi K; Williams K
J Pharmacol Exp Ther; 1997 Nov; 283(2):533-40. PubMed ID: 9353367
[TBL] [Abstract][Full Text] [Related]
4. Comparative studies of anthraquinone- and anthracene-tetraamines as blockers of N-methyl-D-aspartate receptors.
Jin L; Sugiyama H; Takigawa M; Katagiri D; Tomitori H; Nishimura K; Kaur N; Phanstiel O; Kitajima M; Takayama H; Okawara T; Williams K; Kashiwagi K; Igarashi K
J Pharmacol Exp Ther; 2007 Jan; 320(1):47-55. PubMed ID: 17050777
[TBL] [Abstract][Full Text] [Related]
5. Cyclophane and acyclic cyclophane: novel channel blockers of N-methyl-D-aspartate receptor.
Masuko T; Nagaoka H; Miyake M; Metori K; Kizawa Y; Kashiwagi K; Igarashi K; Kusama T
Neurochem Int; 2007 Jan; 50(2):443-9. PubMed ID: 17113196
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotection by tosyl-polyamine derivatives through the inhibition of ionotropic glutamate receptors.
Masuko T; Namiki R; Nemoto Y; Miyake M; Kizawa Y; Suzuki T; Kashiwagi K; Igarashi K; Kusama T
J Pharmacol Exp Ther; 2009 Nov; 331(2):522-30. PubMed ID: 19644042
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of linear and cyclic polyamines on NMDA receptor activities.
Masuko T; Miyake M; Kusama-Eguchi K; Koike T; Kimura E; Kizawa Y; Kashiwagi K; Igarashi K; Kusama T
Neurochem Int; 2008 Jul; 53(1-2):38-44. PubMed ID: 18556092
[TBL] [Abstract][Full Text] [Related]
8. Monoamines directly inhibit N-methyl-D-aspartate receptors expressed in Xenopus oocytes in a voltage-dependent manner.
Masuko T; Suzuki I; Kizawa Y; Kusama-Eguchi K; Watanabe K; Kashiwagi K; Igarashi K; Kusama T
Neurosci Lett; 2004 Nov; 371(1):30-3. PubMed ID: 15500961
[TBL] [Abstract][Full Text] [Related]
9. NR1 and NR2 subunit contributions to N-methyl-D-aspartate receptor channel blocker pharmacology.
Monaghan DT; Larsen H
J Pharmacol Exp Ther; 1997 Feb; 280(2):614-20. PubMed ID: 9023271
[TBL] [Abstract][Full Text] [Related]
10. Antagonism of NMDA receptors by butanesulfonyl-homospermine guanidine and neuroprotective effects in in vitro and in vivo.
Masuko T; Suzuki T; Miyake M; Kusama-Eguchi K; Kizawa Y; Tomono K; Kashiwagi K; Igarashi K; Kusama T
Neurosci Lett; 2012 Jan; 506(2):251-5. PubMed ID: 22119002
[TBL] [Abstract][Full Text] [Related]
11. Antagonist properties of polyamines and bis(ethyl)polyamines at N-methyl-D-aspartate receptors.
Igarashi K; Williams K
J Pharmacol Exp Ther; 1995 Mar; 272(3):1101-9. PubMed ID: 7891322
[TBL] [Abstract][Full Text] [Related]
12. Structural features of the glutamate binding site in recombinant NR1/NR2A N-methyl-D-aspartate receptors determined by site-directed mutagenesis and molecular modeling.
Chen PE; Geballe MT; Stansfeld PJ; Johnston AR; Yuan H; Jacob AL; Snyder JP; Traynelis SF; Wyllie DJ
Mol Pharmacol; 2005 May; 67(5):1470-84. PubMed ID: 15703381
[TBL] [Abstract][Full Text] [Related]
13. Equilibrium constants for (R)-[(S)-1-(4-bromo-phenyl)-ethylamino]-(2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-yl)-methyl]-phosphonic acid (NVP-AAM077) acting at recombinant NR1/NR2A and NR1/NR2B N-methyl-D-aspartate receptors: Implications for studies of synaptic transmission.
Frizelle PA; Chen PE; Wyllie DJ
Mol Pharmacol; 2006 Sep; 70(3):1022-32. PubMed ID: 16778008
[TBL] [Abstract][Full Text] [Related]
14. Block of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors by polyamines and polyamine toxins.
Washburn MS; Dingledine R
J Pharmacol Exp Ther; 1996 Aug; 278(2):669-78. PubMed ID: 8768718
[TBL] [Abstract][Full Text] [Related]
15. Pharmacology of delta2 glutamate receptors: effects of pentamidine and protons.
Williams K; Dattilo M; Sabado TN; Kashiwagi K; Igarashi K
J Pharmacol Exp Ther; 2003 May; 305(2):740-8. PubMed ID: 12606689
[TBL] [Abstract][Full Text] [Related]
16. Design of antagonists for NMDA and AMPA receptors.
Bolshakov KV; Kim KH; Potapjeva NN; Gmiro VE; Tikhonov DB; Usherwood PN; Mellor IR; Magazanik LG
Neuropharmacology; 2005 Aug; 49(2):144-55. PubMed ID: 15996563
[TBL] [Abstract][Full Text] [Related]
17. Selective antagonism of native and cloned kainate and NMDA receptors by polyamine-containing toxins.
Brackley PT; Bell DR; Choi SK; Nakanishi K; Usherwood PN
J Pharmacol Exp Ther; 1993 Sep; 266(3):1573-80. PubMed ID: 7690404
[TBL] [Abstract][Full Text] [Related]
18. An aspartate residue in the extracellular loop of the N-methyl-D-aspartate receptor controls sensitivity to spermine and protons.
Kashiwagi K; Fukuchi J; Chao J; Igarashi K; Williams K
Mol Pharmacol; 1996 Jun; 49(6):1131-41. PubMed ID: 8649353
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological activity of argiotoxin 636 and analogues: selective antagonists for ionotropic glutamate receptors.
Nelson JK; Frølund SU; Tikhonov DB; Kristensen AS; Strømgaard K
Angew Chem Int Ed Engl; 2009; 48(17):3087-91. PubMed ID: 19152392
[TBL] [Abstract][Full Text] [Related]
20. Assessment of structurally diverse philanthotoxin analogues for inhibitory activity on ionotropic glutamate receptor subtypes: discovery of nanomolar, nonselective, and use-dependent antagonists.
Frølund S; Bella A; Kristensen AS; Ziegler HL; Witt M; Olsen CA; Strømgaard K; Franzyk H; Jaroszewski JW
J Med Chem; 2010 Oct; 53(20):7441-51. PubMed ID: 20873775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
